Pola-R-CHP Regimen

Preferred Label : Pola-R-CHP Regimen;

NCIt synonyms : Polatuzumab Vedotin Plus Rituximab-Cyclophosphamide/Doxorubicin/Prednisone Regimen; Polatuzumab Vedotin Plus Rituximab-Cyclophosphamide/Hydroxydaunorubicin/Prednisone Regimen; Pola-R-CHP; Cyclophosphamide/Doxorubicin/Polatuzumab Vedotin/Prednisone/Rituximab Regimen; Polivy Plus Rituxan Plus Cyclophosphamide/Doxorubicin/Prednisone Regimen; Polatuzumab Vedotin Plus Rituximab/Cyclophosphamide/Doxorubicin/Prednisone Regimen;

NCIt definition : A regimen consisting of polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin and prednisone that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL).;

Details

Origin ID

C202587;

chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Polatuzumab Vedotin [NCIt concept]
- Prednisone [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Non-Hodgkin Lymphoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients